Skip to content
OpenCapital
Get started

MiMedx Group MDXG EBIT

EBIT at other companies

IAR
Integra LifeSciencesIART
$11.47M+174%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$68.89M-158%
Vericel logo
VericelVCEL
-$8.06M+37.0%
Enovis logo
EnovisENOV
$6.53M+114%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$1.53M+66.2%
Solventum logo
SolventumSOLV
——

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

−$16.0Moperating income−$15.3Mincome before tax+$886.0Kinterest expense=-$16.05M

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's EBIT?
MiMedx Group (MDXG) reported EBIT of -$16.05M in Q1 2026.
How has MiMedx Group's EBIT changed year-over-year?
MiMedx Group's EBIT decreased by 294.5% year-over-year, from $8.25M to -$16.05M.
What is the long-term trend for MiMedx Group's EBIT?
Over 3 years (2021 to 2025), MiMedx Group's EBIT has grown at a 97.2% compound annual growth rate (CAGR), from -$8.34M to $63.89M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.